Virtus LifeSci Financials

BBC Etf  USD 26.12  0.05  0.19%   
Financial data analysis helps to confirm if markets are presently mispricing Virtus LifeSci. We have analyzed twelve available drivers for Virtus LifeSci Biotech, which can be compared to its competition. The etf experiences a normal downward trend and little activity. Check odds of Virtus LifeSci to be traded at $25.86 in 90 days. Key indicators impacting Virtus LifeSci's financial strength include:
Net Expense Ratio
0.0079
3 y Sharp Ratio
(0.35)
  
The data published in Virtus LifeSci's official financial statements typically reflect Virtus LifeSci's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Virtus LifeSci's quantitative information. For example, before you start analyzing numbers published by Virtus accountants, it's essential to understand Virtus LifeSci's liquidity, profitability, and earnings quality within the context of the Virtus space in which it operates.
Please note, the presentation of Virtus LifeSci's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Virtus LifeSci's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Virtus LifeSci's management manipulating its earnings.

Virtus LifeSci Etf Summary

Virtus LifeSci competes with Virtus LifeSci, ALPS Medical, Loncar Cancer, and First Trust. Under normal market conditions, the fund will invest not less than 80 percent of its assets in component securities of the index. Virtus Lifesci is traded on NYSEARCA Exchange in the United States.
InstrumentUSA Etf View All
ExchangeNYSE ARCA Exchange
ISINUS26923G3011
CUSIP26923G301
RegionNorth America
Investment IssuerVirtus
Etf FamilyVirtus
Fund CategorySector
Portfolio ConcentrationHealth Care
BenchmarkDow Jones Industrial
PhoneNA
CurrencyUSD - US Dollar

Virtus LifeSci Key Financial Ratios

Virtus Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Virtus LifeSci's current stock value. Our valuation model uses many indicators to compare Virtus LifeSci value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Virtus LifeSci competition to find correlations between indicators driving Virtus LifeSci's intrinsic value. More Info.
Virtus LifeSci Biotech is second largest ETF in price to earning as compared to similar ETFs. It is fourth largest ETF in price to book as compared to similar ETFs fabricating about  0.04  of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Virtus LifeSci Biotech is roughly  22.78 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Virtus LifeSci's earnings, one of the primary drivers of an investment's value.

Virtus LifeSci Biotech Systematic Risk

Virtus LifeSci's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Virtus LifeSci volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Virtus LifeSci Biotech correlated with the market. If Beta is less than 0 Virtus LifeSci generally moves in the opposite direction as compared to the market. If Virtus LifeSci Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Virtus LifeSci Biotech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Virtus LifeSci is generally in the same direction as the market. If Beta > 1 Virtus LifeSci moves generally in the same direction as, but more than the movement of the benchmark.

About Virtus LifeSci Financials

What exactly are Virtus LifeSci Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Virtus LifeSci's income statement, its balance sheet, and the statement of cash flows. Potential Virtus LifeSci investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Virtus LifeSci investors may use each financial statement separately, they are all related. The changes in Virtus LifeSci's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Virtus LifeSci's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

Virtus LifeSci Thematic Clasifications

Virtus LifeSci Biotech is part of several thematic ideas from Health Care ETFs to Sector ETFs. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas

Virtus LifeSci November 21, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Virtus LifeSci help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Virtus LifeSci Biotech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Virtus LifeSci Biotech based on widely used predictive technical indicators. In general, we focus on analyzing Virtus Etf price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Virtus LifeSci's daily price indicators and compare them against related drivers.
When determining whether Virtus LifeSci Biotech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Virtus Etf is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Virtus Lifesci Biotech Etf. Highlighted below are key reports to facilitate an investment decision about Virtus Lifesci Biotech Etf:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Virtus LifeSci Biotech. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
The market value of Virtus LifeSci Biotech is measured differently than its book value, which is the value of Virtus that is recorded on the company's balance sheet. Investors also form their own opinion of Virtus LifeSci's value that differs from its market value or its book value, called intrinsic value, which is Virtus LifeSci's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virtus LifeSci's market value can be influenced by many factors that don't directly affect Virtus LifeSci's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virtus LifeSci's value and its price as these two are different measures arrived at by different means. Investors typically determine if Virtus LifeSci is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virtus LifeSci's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.